Lawrence W. Elmer, MD, PhD – FDA Inspection, Feb 18, 2026

Record Details

This FDA Inspection record concerns Lawrence W. Elmer, MD, PhD, with an inspection on February 18, 2026, issued by the Cincinnati District Office, covering human drugs.

Company: Lawrence W. Elmer, MD, PhD
Inspection Date: February 18, 2026
Product Type: Human Drugs
Office: Cincinnati District Office
Person: D'Arbra R. Blankenship (Issuing Officer)

View Company Profile

ID · 70b53eee-3d81-4c82-995e-95f3706768b6

Inspection Facts

Inspection number: 1305496
FDA center: Human Drugs

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lawrence W. Elmer, MD, PhD

FDA Inspection

Lawrence W. Elmer, MD, PhDFebruary 18, 2026

Lawrence W. Elmer, MD, PhD – FDA Inspection, Feb 18, 2026

Record Details

This FDA Inspection record concerns Lawrence W. Elmer, MD, PhD, with an inspection on February 18, 2026, issued by the Cincinnati District Office, covering human drugs.